Pharmacy World and Science

, Volume 24, Issue 6, pp 224–230 | Cite as

Community pharmacists' perspectives on pharmaceutical care implementation in New Zealand

  • John A. Dunlop
  • John P. ShawEmail author


Objective: There were three objectives to this study: to establish New Zealand community pharmacists' level of understanding of the pharmaceutical care process; to determine their attitudes to the concept of pharmaceutical care; and to determine the barriers to commencing pharmaceutical care practice. Comparisons were made between proprietors (pharmacy owners) and employees, males and females, and younger and older pharmacists. Method: The research tool was a questionnaire instrument, encompassing a total of 67 questions designed to determine community pharmacists' understanding, attitudes and appreciation of the opportunities and barriers inherent in the pharmaceutical care process. A total of 490 pharmacists representing 286 proprietors and 204 employees randomly selected from the Pharmaceutical Society register were sent a questionnaire. Results: The total responses numbered 377, which was a 76.9% overall response rate. Over 60% of the pharmacists surveyed had a correct understanding of pharmaceutical care. Approximately the same percentage felt the future of pharmacy would depend on the provision of services other than dispensing. Insufficient time, as a barrier to implementation, was identified by 87% of respondents, and an absence of a reimbursement system by a further 82%. Lack of: therapeutic knowledge; clinical problem solving skills; finance; appropriate space; patient demand; access to patient medical records; and data on the value of PC were identified as major barriers by over 50% of all respondents. There were significant differences in response to a number of issues recorded by males and females, proprietors and employees, and pharmacists above and below the mean sample age of 45 years.Conclusion: This study found that the community pharmacy environment in New Zealand had a high level of understanding of the pharmaceutical care process, but identified some significant barriers to implementation.

Attitudes Barriers Community pharmacy Implementation New Zealand Pharmaceutical Care Pharmacists 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Anon. FIP statement of professional standards: pharmaceutical care. Int J Pharm. 1998;12(5):138.Google Scholar
  2. 2.
    Hepler CD, Strand LM, Opportunities and responsibilities in pharmaceutical care. Am J Pharm Ed 1987;51:369-85.Google Scholar
  3. 3.
    Strand LM. Re-visioning the professions. J Am Pharm Assoc. 1997;NS37:474-8.Google Scholar
  4. 4.
    Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost of illness model. Arch Intern Med 1995;155:1949-56.Google Scholar
  5. 5.
    Classen DC, Pestotnik SL, Scott Evans R, Lloyd JF, Burke JP. Adverse drug events in hospitalised patients. JAMA 1997;277:301-6.Google Scholar
  6. 6.
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalised patients JAMA 1998;279:1200-5.Google Scholar
  7. 7.
    Adamcik BA, Ransford HE, Oppenheimer PR et al. New clinical roles for pharmacists: a study of role expansion. Soc Sci Med 1986;23:1187-200.Google Scholar
  8. 8.
    Zacker C, Mucha L. Institutional and contingency approaches to the re-professionalisation of pharmacy. Am J Health-Syst Pharm 1998;55:1302-5.Google Scholar
  9. 9.
    Becker F. Workplace by design: mapping the high performance workscape. San Francisco: Jossey-Bass Publishers, 1995.Google Scholar
  10. 10.
    Bell HM, McElney JC, Hughes CM, Woods A. An assessment of the extent of provision of pharmaceutical care by community pharmacists. Pharm J 1997;259:R24.Google Scholar
  11. 11.
    Barner JC, Bennett RW. Pharmaceutical care certificate program: assessment of pharmacists' implementation into practice. J Am Pharm Assoc 1999;39:362-7.Google Scholar
  12. 12.
    Foppe van Mil JW, Tromp DF, McElnay JC, et al. Development of pharmaceutical care in The Netherlands: pharmacy's contemporary focus on the patient. J Am Pharm Assoc 1999;39:395-401.Google Scholar
  13. 13.
    Cacciatore GG. The overregulation of pharmacy practice. Pharmacotherapy 1997;17:395-6.Google Scholar
  14. 14.
    Farris KB, Schopflocher DP. Between intention and behaviour: an application of community pharmacists' assessment of pharmaceutical care. Soc Sci Med 1999;49:55-6.Google Scholar
  15. 15.
    Odedina FT, Segal R. Behavioural pharmaceutical care scale for measuring pharmacists' activities. Am J Health Syst Pharm 1996;53:855-65.Google Scholar
  16. 16.
    Anon. Dorset introduces contracts for a range of professional services. Pharm J 1998;260:150.Google Scholar
  17. 17.
    Campbell RK, Saulie BA. Providing pharmaceutical care in a physician office. J Am Pharm Assoc 1998;38:495-9.Google Scholar
  18. 18.
    Moore TJ, Psaty BM, Furberg CD. Time to act on drug safety. JAMA 1998;27919:1571-3.Google Scholar
  19. 19.
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A Meta-analysis of Prospective Studies. JAMA 1998;279(15):1200-4.Google Scholar
  20. 20.
    Leape LL, Cullen DJ et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.Google Scholar
  21. 21.
    Smith DH, Fassett WE, Christensen DB. Washington State CAR Project: downstream cost changes associated with the provision of cognitive services by pharmacists. J Am Pharm Assoc 1999;39:650-7.Google Scholar
  22. 22.
    Hill WT Jr. Harvey A.K. Whitney lecture. Taking charge of the profession. Am J Hosp Pharm 1989;46:1557-61.Google Scholar
  23. 23.
    Kennie NR, Schuster BG, Einarson TR. Critical analysis of the pharmaceutical care literature. Ann Pharmacother 1998;32: 17-25.Google Scholar
  24. 24.
    Proceedings. Implementing pharmaceutical care. Am J Hosp Pharm 1993;50:1585-656.Google Scholar
  25. 25.
    Penna RP. Pharmaceutical Care: Pharmacy's mission for the 1990s. Am J Hosp Pharm 1990;47:543-9.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  1. 1.School of PharmacyUniversity of OtagoDunedinNew Zealand
  2. 2.School of PharmacyUniversity of AucklandAucklandNew Zealand

Personalised recommendations